CarMax stock plummets 20% following ‘challenging’ quarter that missed Wall Street’s expectations

CarMax stock plummets 20% following ‘challenging’ quarter that missed Wall Street’s expectations


A sign is posted in front of a CarMax dealership on April 10, 2025 in Santa Rosa, California. 

Justin Sullivan | Getty Images News | Getty Images

DETROIT — Shares of CarMax were down by more than 20% in early trading Thursday after the used auto retailer missed Wall Street’s quarterly earnings and revenue expectations.

The company’s results included earnings per share of 99 cents and revenue of roughly $6.6 billion, down 6% from a year earlier. Analysts surveyed by LSEG had expected earnings per share of $1.05 and revenue of $7.01 billion.

CarMax CEO Bill Nash described the company’s second fiscal quarter that ended Aug. 31 as “challenging” in the company’s quarterly release.

Other key results, such as sales and net income, were also down compared with a year earlier. The company’s overall vehicle sales fell 4.1% compared with the same period a year earlier, assisting in a roughly 28% decline in net income to $95.4 million.

Shares of other car retailers were also down after CarMax’s results, as many investors and Wall Street analysts watch the company’s performance as an early barometer ahead of other quarterly reporting.

Shares of Group 1 Automotive, Penske Automotive Group, Sonic Automotive and Lithia Motors were all down roughly 2% or less. AutoNation’s stock was off roughly 4%, as was Carvana‘s stock.



Source

Forgotten no more: Generation X is driving beauty sales
Business

Forgotten no more: Generation X is driving beauty sales

Ryan Mckeever | E+ | Getty Images Move over, Sephora kids. While younger generations have been buying beauty products in droves, data shows that a different generation holds more spending power: Generation X. Often dubbed the “forgotten generation,” Gen X spans those born between 1965 and 1980, according to Pew Research Center. Sandwiched between baby […]

Read More
FDA fast-tracks psychedelic drug research following Trump executive order
Business

FDA fast-tracks psychedelic drug research following Trump executive order

FILE PHOTO: Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA) in Washington, U.S. May 7, 2019. DEA | Reuters The U.S. Food and Drug Administration on Friday announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness. That […]

Read More
New York’s pied-a-terre tax sets up legal fight over values
Business

New York’s pied-a-terre tax sets up legal fight over values

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. New York’s proposed tax on second homes worth more than $5 million is likely to spark costly legal battles over how to value […]

Read More